Butler Acquisition Corp
CCXX · NYSE · formerly MultiPlan Corp
NO ACTION REQUIRED
Nothing left to do
The purchase completed and the shares became shares in the company it bought. There is no deadline left to miss.
Cash at settlement
No cash-per-share figure was filed for this vehicle before it finished.
Last close
Daily close
No price history on file yet — daily closes accumulate from the market data feed.
Trust settled · There is no line to draw here. This vehicle has finished: the cash was paid back or spent closing the deal, so the last filed figure describes an account that no longer exists and would be a floor under nothing.
SpacBrain’s read
Trust settled
The deal closed — SPAC shares became the target's shares, so there is no trust left to redeem (nobody missed a window; holders who wanted cash elected it at the vote).
In plain terms
- What it is
- A SPAC, listed on NYSE in February 2020.
- What it's doing now
- It agreed to buy Claritev Corp, a healthcare technology, data and insights company. That purchase completed, and it stopped being a SPAC — the shares became shares in the business it bought.
- What you should know
- This SPAC has finished. The purchase completed, and the shares became shares in the company it bought — anyone who wanted the cash instead asked for it at the vote, so there is no cash left here to claim and no deadline left to miss.
At a glance
- Where it stands
- Closed (deSPAC)
- The business it bought
- Claritev Corp
- Industry
- Health Care — healthcare technology, data and insights
- Deal value
- not stated in the filings we hold
- Price vs cash at settlement
- no live price on file
- Cash in trust when it settled
- not yet extracted into a snapshot — the filings below may state it
- the last trust total filed while this was still a SPAC — the account has since been paid out or used to close the deal
- IPO
- 14 February 2020
- size not on file
- Headquarters
- 7900 TYSONS ONE PLACE, MCLEAN, VA, 22102
- registered in Delaware
- Lead underwriter
- not extracted from the prospectus yet
- Key officers
- Misencik Tiffani (SVP, Chief Growth Officer) · Mintz William B. (SVP, Chief Strategy Officer) · Garis Douglas Michael (EVP&CFO)
- Listed securities
- CCXX common
This vehicle has finished, so there is no window to file a cash-per-share figure for and none will follow. No estimate is shown in its place.
Nothing dated is on file. That is an absence in the record, not a statement that nothing is coming.
Yield to redemption
Nothing left to redeem — no yield to compute.
This SPAC has finished — its trust was paid back or used to close the deal, so there is nothing left to redeem and no yield to compute. A yield to redemption is a claim that you can hand these shares back for the trust cash. That account is closed, so this page will not print a number here.
What happened to the cash
The reasoning behind the verdict above, in the order the filings establish it.
- The deal closed — SPAC shares became the target's shares, so there is no trust left to redeem (nobody missed a window; holders who wanted cash elected it at the vote).
What has happened, and what is coming
1 dated milestoneEvery dated step from the day it listed to the next date you may have to act on. Where you have to do something, the day your broker needs the instruction is marked too.
- 14 February 2020IPOpassed
IPO size not on file
The deal
terms as filedWhat it is buying, on what terms, and how much of the combined company new shares take from you.
- closedHealth Care
What Claritev Corp does — read from claritev.com on 26 August 2026
Claritev is a healthcare technology company that provides AI-enabled solutions aimed at improving transparency, quality, and affordability across the healthcare ecosystem. With over 45 years of healthcare data processing experience, the company offers claims intelligence, data and analytics, network management, and payment and revenue integrity solutions to help organizations reduce costs and make better decisions.
HealthcareHealth InsuranceHealth PlansBrokersEmployersGovernmentDeal structureSEC-primary — BCA 8-K / S-4 / DEFM14A- PIPE
- ≈ $1.3B · unsourced
PIPE terms — instrument, coupon, conversion price and any reset floor — are not sourced for this deal. The size above is itself unsourced — a stored figure no filing we hold states — so neither the size nor the terms should be read as cited.
stated in:0001104659-20-106245
The score
deterministic, from filed fieldsCCXX is not in the scored universe, so no score is shown. A withheld score is a fact about the record, not a verdict about the company.
The score is only published for names that carry both a price and a filed cash-per-share figure — 294 of the tracked fleet today. The rest keep an empty dial rather than a modelled one, and fill in by themselves as the fields land.
The company
from SEC filingsRead the full profile
Butler Acquisition Corp was a blank-check company whose common stock traded on the New York Stock Exchange under the ticker CCXX. The company priced its initial public offering on February 14, 2020, under SEC file number 333-236153, pursuant to an S-1 registration statement filed on January 29, 2020. The registrant self-described as a blank check company in its 424B4 prospectus and was classified under SEC SIC industry code 7389, Services-Business Services, NEC. On October 9, 2020, the company filed an 8-K reporting a change in shell company status under item 5.06, establishing that it had completed a business combination and no longer files as a blank-check vehicle. EDGAR now lists SEC CIK 0001793229 under the name Claritev Corp.
Material findings
from the full read of every filingEvery document this company files gets read whole — body and exhibits. These are the ones the read flagged as material, newest first, each citing its filing.
Adjusted EBITDA is 60.5% of revenue while the company reports a $59.2 million net loss, and full-year free cash flow guidance of $5–15 million is small against $610–620 million of guided Adjusted EBITDA and $160–170 million of capex. Bookings are a leading indicator management cites, not recognised revenue.
Roughly 87% of total assets is goodwill and intangibles, and accrued interest alone at $99.7 million is nearly seven times unrestricted cash of $14.4 million. The intangible balance fell $171.8 million over the half-year through amortization.
The NYSE has set a hard endpoint: if a $1.00 share price and a $1.00 average price over the preceding 30 trading days are not attained by the expiration of the six-month cure period, the exchange will commence suspension and delisting procedures, and it reserves the right to reevaluate its determination for companies notified of non-compliance. With 658,127,871 shares outstanding, the split is the only mechanism that can move the price fast enough within that window.
The cash half is a residual, not a fixed sum: it is the trust account after redemptions, plus subscription money funded and still held, minus the aggregate principal of MultiPlan Parent's 8.500% / 9.250% Senior PIK Toggle Notes due 2022 — and it is capped at $1,521,000,000. Everything not paid in cash is paid in Class A common stock at $10.00 per share, so redemptions shift consideration from cash into stock rather than shrinking the deal. The NYSE proposal covers issuing more than 20% of the stock, issuing more than 20% to a single holder, and issuing to a Related Party.
The cash component is a formula with a hard ceiling: all trust amounts after redemption payments, plus subscription cash funded to and remaining with Churchill immediately before closing, minus the aggregate principal amount of MultiPlan Parent's outstanding 8.500% / 9.250% Senior PIK Toggle Notes due 2022 — and in no event more than $1,521,000,000. Since the total consideration is fixed, every dollar redeemed shifts consideration out of cash and into Churchill Class A stock, so redemptions dilute the remaining public holders rather than reducing the seller's price.
Filings
live EDGAR feedEverything this company has filed with the SEC recently, newest first, each with a plain summary of what changed and why it matters.
What changed: Exhibit 99.1 to an 8-K of Claritev Corporation (NYSE: CTEV): the August 7, 2026 press release reporting Q2 2026 results. Revenues were $257.5 million, up 6.6% from $241.6 million; net loss was $59.2 million against $62.6 million; Adjusted EBITDA was $155.8 million, up 1.1% from $154.0 million, at a 60.5% margin against 63.8%. Net cash provided by operating activities was $92.7 million versus $61.2 million and free cash flow $54.6 million versus $36.6 million; the company ended the quarter with $14.4 million of unrestricted cash. Why it matters: Adjusted EBITDA is 60.5% of revenue while the company reports a $59.2 million net loss, and full-year free cash flow guidance of $5–15 million is small against $610–620 million of guided Adjusted EBITDA and $160–170 million of capex. Bookings are a leading indicator management cites, not recognised revenue.
Show the other 10 filings
What changed: Q2 2026 10-Q of Claritev Corporation (NYSE: CTEV), with 16,947,463 Class A shares outstanding as of August 3, 2026. Cash and equivalents were $14,373 thousand at June 30, 2026 versus $16,814 thousand at December 31, 2025, with restricted cash of $13,302 thousand and trade accounts receivable of $130,901 thousand; total current assets were $236,418 thousand. Non-current assets are dominated by goodwill of $2,405,853 thousand and other intangibles, net of $1,712,788 thousand, with property and equipment of $359,561 thousand, giving total assets of $4,763,857 thousand versus $4,888,458 thousand. Why it matters: Roughly 87% of total assets is goodwill and intangibles, and accrued interest alone at $99.7 million is nearly seven times unrestricted cash of $14.4 million. The intangible balance fell $171.8 million over the half-year through amortization.
What changed: Claritev Corporation, the Churchill Capital Corp III successor, reported that on July 6, 2026 it was notified of the death of John Prince, who had served on the board of directors since June 2023 and was a member of the Audit Committee at the time of his death. No successor is named and no committee reassignment is disclosed. The report is signed by Executive Vice President and Chief Financial Officer Douglas M. Garis. Why it matters: The immediate governance consequence is a vacancy on the Audit Committee, which exchange rules require to have a minimum number of independent members — so a replacement will have to be appointed within the applicable cure period if the committee falls below that threshold. Nothing here affects a trust, a redemption right or a deadline from the former CCXX vehicle, and no financial or operational matter is implicated.
The sponsor
The people who set this company up, what they have done before, and the advisers around the deal.
No sponsor entity is named in the filings parsed for this SPAC so far.
A missing score, not a score of zero — why
A Sponsor Score is only published once the sponsor’s prior vehicles have been verified on EDGAR and their post-close outcomes priced. That record does not exist for this sponsor yet, so no number and no tier is shown. That is a missing score, not a score of zero — and not a neutral 50 either.
Coverage so far: 301 of 1284 tracked SPACs (23%) are attached to a scored sponsor. This card fills in by itself as the research lands.
The record
The reference detail — how the shares were structured at listing, how thinly they trade, and where the company is registered.
Show the reference detail
Unit structure
from 424B3 0001104659-25-111757
Trading & liquidity
Company profile
Directors & officers
- Misencik TiffaniSVP, Chief Growth Officer
- Mintz William B.SVP, Chief Strategy Officer
- Garis Douglas MichaelEVP&CFO
- Albinson BrockSVP, Chief Accounting Officer
- Carol NutterSVP, Chief People Officer
- Kim MichaelEVP, Chief Digital Officer
- Prince John MichaelDirector
Institutional holders
from SC 13G/13DFunds that have declared a stake above 5%. Heavy ownership by arbitrage funds usually means heavy cash-outs at the next vote.
Show the declared stakes
12 filers with a stake on file · 0 re-affirmed in the last 12 months. A stake with no amendment since is the filer’s last word on it, not proof it is still held — and percentages filed in different years are percentages of different floats, because this vehicle’s share count collapses at every redemption.
- Hellman & Friedman Investors VIII, L.P.with 10 other reporting persons on the same schedule33.7% · SC 13D/AMay 13, 2022 stale
- WELLINGTON MANAGEMENT GROUP LLPwith 3 other reporting persons on the same schedule10.7% · SC 13G/ANov 10, 2020 stale
- PUBLIC INVESTMENT FUND9.5% · SC 13G/AFeb 12, 2024 stale
- GIC Private Ltdwith 2 other reporting persons on the same schedule7.8% · SC 13G/AFeb 11, 2022 stale
- Green Equity Investors VI, L.P.with 8 other reporting persons on the same schedule5.8% · SC 13DOct 13, 2020 stale
- Klein Michael Stuart5.7% · SC 13G/AFeb 14, 2024 stale
- VANGUARD GROUP INCwith 1 other reporting person on the same schedule5.6% · SC 13G/ANov 12, 2024 stale
- Magnetar Financial LLCwith 2 other reporting persons on the same schedule5.4% · SC 13GFeb 16, 2021 stale
- MMCAP International Inc. SPCwith 1 other reporting person on the same schedule5.0% · SC 13G/AFeb 10, 2021 stale
- PRICE T ROWE ASSOCIATES INC /MD/with 1 other reporting person on the same schedule2.1% · SC 13G/AFeb 14, 2023 stale
- Linden Capital L.P.with 2 other reporting persons on the same schedule0.1% · SC 13G/AFeb 4, 2021 stale
- MPH Acquisition Holdings LLCwith 5 other reporting persons on the same schedule0.0% · SC 13D/AOct 13, 2020 stale
One line per filer, not per reporting person: a joint schedule names the management company, its funds and often the individual who controls them, and all of them report the same shares. Click a name for that filer’s whole footprint across every SPAC it has declared a stake in.
News
company wires and the financial pressReporting we have matched to this ticker. Headlines belong to the outlets that wrote them.
Show the headlines
- Claritev and SAVVI Financial Collaborate to Deliver Next Generation Healthcare Benefit Decision Support
PR Newswireundated by the source
- Claritev Demonstrates Market Leadership as Federal No Surprises Act Disputes Reach Record Levels
Business Wireundated by the source
Sources on file
harvested pages, kept in fullEvery public page we have read about this company, stored in full so a source can never go missing.
Show the sources
32 full SEC filing texts archived — searchable, never lost.
- Vault note — CCXX (Butler Acquisition Corp)
vault-note · /vault/tickers/CCXX
- Vault deal note — Claritev Corp (CCXX)
vault-note · /vault/deals/claritev-corp
- Ihre Datenschutzeinstellungen
news · consent.yahoo.com
- Claritev Company Overview, Contact Details & Competitors | LeadIQ
news · leadiq.com
- Healthcare Provider Network Management Solutions | Claritev
company-site · claritev.com
- Healthcare Analytics Solutions for Health Plans | Claritev
company-site · claritev.com
- Claims Analytics Solutions for Healthcare Payers | Claritev
company-site · claritev.com
- Healthcare Technology Solutions | Claritev
company-site · claritev.com
In plain English
tap a term to open itEvery piece of jargon this page could have used, and what it actually means.
Open the plain-English guide
No floor / floorlessthe cash guarantee is gone — the price is unprotected
A SPAC's downside protection is not the cash in trust; it is your right to demand that cash. Once the redemption window closes, the cash stays with the company and the share can trade anywhere.
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Broker action datethe day your broker needs the instruction — earlier than the official date
Brokers batch redemption instructions to the transfer agent, so the practical cutoff is roughly two business days before the published deadline. This is the date that actually costs people the floor.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Trust discountbuying below the cash held for you
Only meaningful while a redemption right exists. On a floorless name the same arithmetic is not a discount, it is the market pricing distress, and this product will not call it a yield.
Dilutionhow much of the company new shares take from you
Sponsor promote, PIPE shares, warrants and rights all issue stock that did not pay $10 for it. The headline deal value is before that; the effective value is after.
Pro-forma equitywhat the company is valued at once the deal closes
The combined company's equity value assuming the announced terms and the redemptions that have actually happened.
ARShow much upside you get per unit of downside
SpacBrain's asymmetric-return score. It is deterministic — the same inputs always produce the same number — and it is capped, not zeroed, when the floor is gone.
De-SPACthe day the SPAC becomes the real company
The shares stop being a claim on a pot of cash and start being equity in an operating business. Roughly 80% of recent de-SPACs traded below $10 within a year.
Outside datethe contractual long-stop for closing the deal
A deadline between the SPAC and its target, not between the SPAC and you. It confers no right to cash, which is exactly why it must never be counted as a redemption window.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.
Accreted NAV (estimate)the last filed cash figure, plus the interest it should have earned since
A model, not a filing: last filed value compounded at the 3-month T-bill for the days elapsed. Always shown in italic with the word estimate, and never printed beside a filed number without it.
Ask the brain
from its filingsData provenance & audit trail5 internal entries
Written by SpacBrain’s data agents whenever a figure is captured, corrected or flagged, and kept verbatim so every number on this page can be traced back to the filing that states it. This is a running log, not the current record: an early entry may be superseded by a later correction — the panels above always hold the current values.
admitted from EDGAR's QUARTERLY FORM INDEX, walked without any SIC filter. The SIC 6770 census could not reach this registrant: EDGAR reassigns a shell's SIC the day it stops being one, and this CIK now files under 7389 (Services-Business Services, NEC). The screen found it by filing SHAPE instead — S-1 2020-01-29 → 8-A12B 2020-02-12 → 424B4 2020-02-14 — which nothing rewrites. Admission rule: src/lib/universe-admit.ts. SIC 7389 + self-described blank check in 424B4 0001104659-20-022036; 424B 0001104659-20-022036 priced 2020-02-14 under S-1 0001104659-20-008163 (file 333-236153, an offering for cash); common ticker CCXX off 10-Q 0001104659-20-093979 (2020-08-12); lifecycle EXITED. The pricing prospectus was filed under SEC file number 333-236153, which belongs to S-1 0001104659-20-008163 (2020-01-29) — a registration of shares sold for CASH, which is what makes it an IPO rather than merger consideration. Blank-check status from the registrant's own first-person sentence in that prospectus (EDGAR full-text search, 424B4 2020-02-14). Ending PROVEN, not inferred: CLOSED per 8-K 0001104659-20-113620 (2020-10-09) — 8-K item 5.06 "Change in Shell Company Status" (EDGAR item index, items: 1.01,2.01,3.02,4.01,5.01,5.03,5.06,5.07,9.01). EDGAR now files this CIK as "Claritev Corp" — the SPAC's own name is kept here and the successor is the target. ipoSizeM and deadline left NULL: gross-proceeds prose conflates the over-allotment with the offering, and a charter deadline belonging to a vehicle that has ended is a date nobody can act on. ipoDate is the 424B pricing date.
[CLOSED-RENAME] EDGAR CIK 0001793229 records "Churchill Capital Corp III" ending 2020-10-06; the registrant continues as "Claritev Corp". The rename is the SEC's own record of what the vehicle became, keyed by CIK. Closed 2020-10-06. No deal value is set — a rename says what was acquired, never for how much. No date column is set: Deal has announcedAt, voteDate and expectedCloseAt and nowhere to record an actual close, so the SEC's date is kept here until that column exists. [DEAL-STRUCTURE-MINED] pipeSizeM=1300 from primary filings (0001104659-20-106245).
entity created from the filed target name; no About paragraph on file, so every other field awaits a sourced read
pipeBasis set to UNSOURCED: the size came from the research seed / an earlier record and no filing we hold states it — surfaces now label it "unsourced"; an LLM re-read to FILED replaces this when credits allow
OTHER -> HEALTHCARE, on 8-K 0001793229-26-000065: "Claritev is a healthcare technology, data, and insights company focused on delivering affordability, transparency, and quality across the healthcare system."